# Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer

> **NCT00643877** · PHASE3 · UNKNOWN · sponsor: **Fudan University** · enrollment: 600 (estimated)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **PROCEDURE:** Preoperative hepatic and regional arterial chemotherapy using oxaliplatin, MMC and FUDR
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT00643877
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2009-12
- **Final completion:** 2014-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2009-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643877, "Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00643877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*